| ¿µ¹® | VDRL(venereal disease research laboratory) | ÇÑ±Û | ¼ºº´ ¿¬±¸½ÇÇè½Ç |
|---|---|---|---|
| ¼³¸í | ¸Åµ¶±ÕÀÇ reagin¿¡ ´ëÇÑ Ç×ü. ¸Åµ¶ÀÇ ¼±º°°Ë»ç·Î »ç¿ëµÇ¸ç ¸Åµ¶ Ä¡·á¿¡ ´ëÇÑ ¹ÝÀÀ ¿©ºÎ¿Í Ä¡·áÈ¿°ú ÆÇÁ¤¿¡µµ »ç¿ëµÈ´Ù. ¸Åµ¶¿Ü¿¡µµ Àü½Å¼ºÈ«¹Ý¼º³¶Ã¢, ·ù¸¶Æ¼½º°üÀý¿° µî¿¡¼µµ ¾ç¼ºÀ¸·Î ³ªÅ¸³¯ ¼ö ÀÖ´Ù. |
||
| ¿µ¹® | Dilatation and Curettage(D & C) | ÇÑ±Û | Àڱñܾ¼ú, ÀڱøñÈ®Àå |
|---|---|---|---|
| ¼³¸í | ÀÚ±ÃÀ̶õ žư¡ ¼öÅÂµÇ¾î¼ ºÐ¸¸Àü±îÁö ¹ßÀ°ÇÏ°í ¼ºÀåÇÏ´Â °ø°£ÀÌ´Ù. Àڱüӿ¡ º´º¯ÀÌ ÀÖ¾î ÀÓ½ÅÀÌ °è¼ÓµÉ ¼ö ¾ø°Å³ª ¾Æ´Ï¸é ´Ù¸¥ ÀÌÀ¯·Î ÀӽŵǾî Àִ žƸ¦ Á¦°ÅÇϰíÀÚ ÇÒ °æ¿ì¿¡ »ç¿ëµÇ´Â ¹æ¹ýÀÌ´Ù. ¿©±â¼ ±Ü¾î³»±â À§ÇÏ¿©´Â ¿ì¼± ÀÚ±ÃÀÇ ÀÔ±¸¿¡ ÇØ´çÇÏ´Â ÀڱøñÀ» È®Àå½ÃÄÑ¾ß ÇÑ´Ù. ¿©±â¿¡´Â ±Þ¼ÓÈ÷ È®ÀåÀ» ½ÃµµÇÏ´Â ¹ý°ú ¼¼È÷ È®ÀåÀ» ½ÃµµÇÏ´Â 2°¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ÀڱøñÀ» ±Þ¼ÓÈ÷ È®ÀåÇÒ ¶§´Â Çì°¡¸£ ¸ñ°üÈ®Àå±â(Hegar's dilatator)¸¦ »ç¿ëÇÑ´Ù. À̰ÍÀº ÀÛÀº ±Ý¼Ó¸·´ë·Î ÀÛÀº Å©±âºÎÅÍ Å« Å©±â±îÁö ´Ù¾çÇÑ Å©±â°¡ ÀÖ¾î¼ ¿ì¼± ÀÛÀº ¸·´ë·Î ½ÃÀÛÇÏ¿© Á¡Á¡ Å« Å©±âÀÇ ¸·´ë¸¦ Àڱøñ¿¡ ³Ö¾î¼ ÀڱøñÀ» È®Àå½ÃŲ´Ù. ¼¼È÷ È®Àå½Ãų ¶§´Â Laminaria tent¸¦ ¸ñ°ü¿¡ »ðÀÔÇÏ´Â ¹æ¹ýÀ» »ç¿ëÇÑ´Ù. Laminaria tent¶õ ÇØÃÊ·Î ¸¸µç ÀÛÀº ¸·´ë·Î ¼öºÐÀ» Èí¼öÇϸé Á¡Á¡ ´Ã¾î³ª´Â ¼ºÁúÀÌ ÀÖ´Ù. À̰ÍÀ» ÀÚ±ÃÀÇ ¸ñ¿¡ ³ÖÀ¸¸é À̰ÍÀÌ ¼öºÐÀ» Èí¼öÇÏ¿© ´Ã¾î³ª¹Ç·Î õõÈ÷ ÀÚ±ÃÀÇ ¸ñÀÌ ´Ã¾î³´Ù. ÀڱøñÀÌ ÃæºÐÈ÷ ´Ã¾î³ª¸é ±× ¼ÓÀ¸·Î ³¡ÀÌ ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ ³Ö¾î¼ ÀڱüÓÀÇ º´º¯À̳ª ÀÓ½ÅµÈ Å¾Ƹ¦ ±Ü¾î³»´Âµ¥ ¿©±â¿¡ »ç¿ëµÇ´Â ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ Å¥·¿À̶ó°í ÇÑ´Ù. Ãʱâ ÀÓ½ÅÁßÀý Áï À¯»ê°ú °°Àº ÀӽŰú °ü·ÃµÈ °æ¿ì»Ó¸¸ ¾Æ´Ï¶ó, ºñÀӽŠÀÚ±ÃÀÇ Àڱ󻸷Á¶Á÷ÀÇ Ã¤Ãë ¹× Á¦°Å¸¦ À§Çؼµµ ÇàÇØÁö´Â ¼ö±âÀÌ´Ù. ÀÌ´Â ¿øÄ¢ÀûÀ¸·Î ¸¶ÃëÇÏ¿¡ ½Ç½ÃµÇ´Â °ÍÀ¸·Î Àڱøñ°üÀ» È®ÀåÇÏ°í ±â±¸·Î Àڱà ³»¿ë¹°À» Á¦°ÅÇϰí Å¥·¿À¸·Î Àڱ󻺮À» ±ú²ýÀÌ ÇÑ´Ù. ÀÚ±Ãõ°øÀ̳ª ÀڱøñÀÇ ÆÄ¿ µîÀÇ À§ÇèÀÌ µû¸£¸ç, ¼ö¼úÈÄ °¨¿° ¶Ç´Â ÃâÇ÷ µî¿¡ ´ëÇÑ ÁÖÀǰ¡ ÇÊ¿äÇÏ´Ù. |
||
| ¿µ¹® | childhood diabetes | ÇÑ±Û | ¼Ò¾Æ´ç´¢º´ |
|---|---|---|---|
| ¼³¸í | ¼Ò¾Æ¿¡ ³ªÅ¸³ª´Â ´ç´¢º´. ´ç´¢º´Àº Àν¶¸° ºÎÁ·À¸·Î ü³» Æ÷µµ´ç ÀÌ¿ëÀÌ ÀúÇϵǾî ź¼öȹ°-Áö¹æ-´Ü¹éÁú ´ë»ç°¡ ÀåÇØ¸¦ ÀÏÀ¸Å°´Â Áúº´À¸·Î, ¼ºÀÎÇü ´ç´¢º´°ú ¿¬¼ÒÇü ´ç´¢º´ÀÌ ÀÖ´Ù. ¼ºÀÎÇüÀº Àν¶¸°ÀÇ »ó´ëÀû ºÎÁ·, Áï ºñ¸¸À¸·Î ÀÎÇÑ Àν¶¸° °¨¼ö¼ºÀÇ ÀúÇÏ °á°ú Àν¶¸° Çʿ䷮ÀÇ Áõ´ë¿¡¼ ¿À´Â °ÍÀ̸ç, ¼Ò¾ÆÇü ´ç´¢º´Àº ÀÌÀÚÀÇ ¶û°Ô¸£Çѽº¼¶ º£Å¸(¥â)¼¼Æ÷ÀÇ ÀåÇØ·Î ÀÎÇÑ Àν¶¸°ÀÇ Àý´ëÀû °áÇÌ¿¡¼ ¿Â´Ù. ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ ±ÇÀåÀ¸·Î 15¼¼ ÀÌÀü¿¡ ¹ßº´ÇÏ´Â ´ç´¢º´À» ¸ðµÎ ¼Ò¾Æ´ç´¢º´À̶ó Çϴµ¥, ¾î¸°ÀÌ¿¡°Ôµµ °£È¤ ¼ºÀÎÇü(¶Ç´Â ºñ¸¸Çü) ´ç´¢º´ÀÌ ÀÖÀ¸¹Ç·Î ¼Ò¾Æ´ç´¢º´À̶ó ÇÔÀº ¼Ò¾Æ±â¿¡ ¹ßº´ÇÏ´Â ¼Ò¾ÆÇü°ú ¼ºÀÎÇü ´ç´¢º´ÀÇ ÃÑĪÀ̶ó ÇÒ ¼ö ÀÖ´Ù. ÇöÀç±îÁö Åë°è¿¡ ÀÇÇϸé ÀüüÀα¸ÀÇ ¾à 5%´Â ´ç´¢º´À» °¡Áö°í ÀÖÀ¸¸ç, ±× °¡¿îµ¥ ¾à 2%°¡ 15¼¼ ÀÌÀü¿¡ ¹ßº´ÇÏ´Â °ÍÀ¸·Î ¾Ë·ÁÁ³´Ù. |
||
| ¿µ¹® | diabetes insipidus | ÇÑ±Û | ¿äºØÁõ |
|---|---|---|---|
| ¼³¸í | 1ÀÏ ¼Òº¯ÀÇ ¾çÀÌ 4~15¸®ÅÍ·Î º´ÀûÀ¸·Î Áõ°¡ÇÏ´Â »óÅÂ. ÀÌ Áõ»óÀº ³úÀÇ ¹Ù´Ú¿¡ ºÙ¾î Àִ ȣ¸£¸óÀ» ÁÖ·Î ºÐºñÇÏ´Â ÀÛÀº ±â°üÀÎ ³úÇϼöü ÈÄ¿±¿¡¼ ºÐºñµÇ¾î ¼öºÐÀÇ Èí¼ö¸¦ ÃËÁøÇÏ¿© ü³»¿¡ ¼öºÐÀÇ ¾çÀ» ´ÃÀÌ´Â ¿ªÇÒÀ» ÇÏ°í µ¿½Ã¿¡ Ç÷°üÀ» ¼öÃà½ÃŰ´Â ÀÛ¿ëÀÌ ÀÖ¾î Ç÷¾ÐÀ» »ó½Â½ÃŰ´Â ¿ªÇÒµµ ÇÏ´Â ADH(Ç×ÀÌ´¢È£¸£¸ó)ÀÇ ºÎÁ·¿¡ ÀÇÇÑ´Ù. ADH°¡ ºÎÁ·µÉ °æ¿ì¿¡´Â ÄáÆÏ¿¡¼ ¼öºÐÀÇ Èí¼ö°¡ ÀϾÁö ¾Ê¾Æ¼ ¸¹Àº ¾çÀÇ ¼öºÐÀÌ ½ÅÀåÀ» ÅëÇØ °É·¯Á®¼ ¼Òº¯À¸·Î ³ª¿À°Ô µÈ´Ù. |
||
| ¿µ¹® | IDDM(Insulin-Dependent Diabetes Mellitus) | ÇÑ±Û | Àν¶¸°ÀÇÁ¸´ç´¢º´ |
|---|---|---|---|
| ¼³¸í | IDDMÀº ´ç´¢º´ÀÇ Ä¡·á¿¡ ¹Ýµå½Ã Àν¶¸°ÀÌ ÇÊ¿äÇÑ °æ¿ì¸¦ ¸»ÇÑ´Ù. ÁÖ·Î ¿øÀÎÀÌ ÀÌÀÚ¿¡ ÀÖ´Â Àν¶¸°À» ºÐºñÇÏ´Â ¼¼Æ÷ÀÇ ÆÄ±«À̸ç ÀÌ·Î ÀÎÇØ¼ ´ç´¢º´ÀÇ Ä¡·áÁ¦·Î ¾²ÀÌ´Â Àν¶¸°ÀÇ ºÐºñ¸¦ ÃËÁøÇÏ´Â ¾à¹°ÀÌ ÀÌ IDDM¿¡¼´Â ¾²ÀÏ ¼ö°¡ ¾ø°í ¿ÀÁ÷ Àν¶¸°¸¸ÀÌ Ä¡·áÁ¦·Î ¾µ ¼ö°¡ ÀÖ´Ù. ÀüÇüÀûÀÎ Àν¶¸° ÀÇÁ¸Çü ´ç´¢º´Àº ¼Ò¾Æ¿¡¼ ÈçÈ÷ ¹ß»ýÇϰí Àν¶¸° ºÐºñ¼¼Æ÷ÀÇ ÆÄ±«¿¡ ÀÇÇØ¼ Àν¶¸° ºÐºñ´ÉÀº °ÅÀÇ ¾ø´Ù. |
||
| CP | candle power; capillary pressure; cardiac pacing; cardiac performance; cardiopulmonary; caudate puta... |
|---|---|
| CR | calculation rate; calculus removed; calorie-restricted; cardiac rehabilitation; cardiac resuscitatio... |
| IPA | immunoperoxidase assay; incontinentia pigmenti achromians; independent physician or practice associa... |
| HCTS | high cholesterol and tocopherol supplement |
| HPS | Hantavirus pulmonary syndrome; hematoxylin, phloxin, and saffron; Hermansky-Pudlak syndrome; high-pr... |
| ECGS | Endothelial Cell Growth Supplement |
|---|---|
| GPRD | General Practice Research Database |
| CPG | Clinical Practice Guideline |
| GCP | Good Clinical Practice |
| CPCRA | Community Programs for Clinical Research in AIDS |
| supplement | Something that supplies a want or make an addition: something that completes, adds a finishing touch or brings closer to completion or a desired state. (18 Nov 1997) |
|---|---|
| clinical nursing research | Research carried out by nurses in the clinical setting and designed to provide information that will help improve patient care. Other professional staff may also participate in the research. (12 Dec 1998) |
| clinical research trials | Evaluating the safety and effectiveness of medications or medical devices by monitoring their effects on large groups of people. Clinical medical trials sponsored by the U. S. Government are listed on a web site of the National Institutes of Health (NIH). The NIH Clinical Centre intends to make details of current clinical research studies for various diseases available over the Internet to increase opportunities for patients and physicians to participate in clinical investigations. (12 Dec 1998) |
| united states agency for health care policy and research | An agency of the public health service established in 1990 to "provide indexing, abstracting, translating, publishing, and other services leading to a more effective and timely dissemination of information on research, demonstration projects, and evaluations with respect to health care to public and private entities and individuals engaged in the improvement of health care delivery.." it supersedes the national centre for health services research. (12 Dec 1998) |
| diabetes and fibre | Soluble fibres (oat bran, apples, citrus, pears, peas/beans, psyllium, etc.) slow down the digestion of carbohydrates (sugars), which results in better glucose metabolism. Some patients with the adult-onset diabetes may actually be successfully treated with a high-fibre diet alone, and those on insulin, can often reduce their insulin requirements by adhering to a high-fibre diet. (12 Dec 1998) |
| Venereal Disease Research Laboratory | <microbiology> A blood test used to diagnose syphilis. Read as nonreactive or negative if you do not have syphilis. The Venereal Disease Research Laboratory can also be positive is cases of leprosy, malaria, mononucleosis, lupus, hepatitis A and pregnancy. Positive Venereal Disease Research Laboratory tests are usually followed up by a more specific test (FTA antibodies). (12 Jan 1998) |
| Medical Research Council | <organisation> A UK Government funded body to promote the balanced development of medical and related biological research in the United Kingdom. It organises national clinical trials for the assessment of new treatment protocols for leukaemia and some of the related diseases. (05 Jan 1998) |
| research | Careful, a diligent search, a close searching, studious inquiry or examination. (18 Nov 1997) |
| research, controlled | The first controlled clinical research was probably done in 1875 by the british naval surgeon james lind who, on board the hms salisbury, gave sailors with scurvy either oranges or lemons or cider or vinegar or nutmeg (or another treatment) and after just six days discovered that the citrus-consuming sailors had recovered from scury, until then the scourge of extended sea voyages, while the sailors who had been given the other treatments remained uncured. (12 Dec 1998) |
| research design | A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly. (12 Dec 1998) |
| research personnel | Those individuals engaged in research. (12 Dec 1998) |
| research support | Financial support of research activities. (12 Dec 1998) |
| peer review, research | The evaluation by experts of the quality and pertinence of research or research proposals of other experts in the same field. Peer review is used by editors in deciding which submissions warrant publication, by granting agencies to determine which proposals should be funded, and by academic institutions in tenure decisions. (12 Dec 1998) |
| controlled thermonuclear research | General label for research on controlled thermonuclear fusion reactions. (09 Oct 1997) |
| health outcomes research | The measurement of the value of a particular course of therapy. Health outcomes research is based on the principle that every clinical intervention produces a change in the health status of a patient and that change can be measured. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|